Synthetic GLP-1s' popularity is growing and so is their influence on the market

While Eli Lilly & Co and Novo Nordisk are leading the industry, pharmaceutical companies are working overtime to produce biosimilars. How does the increased use of these drugs threaten to disrupt the market across industries?

The $5.5B Fund That Just Went All-In on AI Infrastructure

Ex-OpenAI researcher Leopold Aschenbrenner is about to file his next 13F. His last quarter's picks are up big. Rounds and Hickenlooper break the STOCK Act.

Rep. Salazar Bought Corning Stock 12 Days Before Meta's $6B Deal

Howard Marks strategy +4.93%. OpenAI missed targets ORCL -4%, SoftBank -10%. Everforth CEO buys $1M. Charter directors buy $2.37M.

Introducing four new API endpoints

Pay vs. Performance: Do CEOs' payouts reflect their company's success?

Quiver Quantitative's new executive compensation data parses SEC filings to identify the top compensated individuals from 2025. But with fixed salaries being only a fraction of the total payout, many executives rely on awards from long-term incentives based on company performance.

Someone Made $20M Trading Trump Announcements Before They Happened

Preview: BBC investigation. Senate demands answers. Plus: AEVEX insiders bought $1M at IPO & the stock doubled in 48 hours.

Why a billionaire just bet $48M on Flutter

Petrodollar dominance explained in 60 seconds. Plus $8.7M in Congress trades nobody's talking about.

Bleeding Boundaries: How Congress is Profiting from Palantir, and Vice-Versa

CoreWeave Execs Dump $146M

Senators demand SEC insider trading probe. Strategies +7.55%. Plus: the Congressman with 150+ trades.

Gottheimer Bought Exxon. Then Hormuz Closed.

A $2.6B Musk verdict, SEC leadership in freefall, and $5.7M in new Congress trades this week.

Letlow Bought DRS. Then Two Pentagon Contracts Followed.

She's the only member of Congress who traded it. Her broker says it was discretionary. DRS is up 14%.

Congress trading in Defense: What are they buying?

Over the past six months, several members of Congress have reported purchasing stocks in some of the largest federally contracted defense companies, including Lockheed Martin, General Dynamics, and Raytheon.